Indian Pharmaceutical Industry: Future Growth and Strategic Focus

The Indian pharmaceutical industry is currently valued at approximately $60 billion. Projections indicate this value is expected to double by 2030.

Projections indicate the Indian pharmaceutical industry's value is expected to double by 2030.

Industry Foundation

The industry's foundation is largely built upon its generics manufacturing capabilities. This established manufacturing strength is now positioning the sector for significant competition regarding semaglutide.

This established manufacturing strength is now positioning the sector for significant competition regarding semaglutide.

Semaglutide Outlook

Semaglutide, an injectable medication, has historically been costly and primarily available to affluent patients. It is anticipated that the drug will become more widely accessible in the future.